UK Markets closed

H. Lundbeck A/S (LUN.CO)

Copenhagen - Copenhagen Real-time price. Currency in DKK
Add to watchlist
165.45-0.55 (-0.33%)
At close: 04:59PM CET
Full screen
Previous close166.00
Open164.20
Bid164.40 x 0
Ask165.45 x 0
Day's range162.00 - 165.45
52-week range150.75 - 260.40
Volume231,722
Avg. volume331,026
Market cap32.875B
Beta (5Y monthly)0.73
PE ratio (TTM)17.56
EPS (TTM)9.42
Earnings date07 Feb 2022 - 11 Feb 2022
Forward dividend & yield2.50 (1.50%)
Ex-dividend date24 Mar 2021
1y target est223.81
  • Zacks

    Are These Medical Stocks Undervalued Right Now?

    Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

  • Zacks

    H. Lundbeck (HLUYY): Strong Industry, Solid Earnings Estimate Revisions

    H. Lundbeck (HLUYY) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

  • Reuters

    Drugmaker Lundbeck lowers sales outlook as generic competition bites

    Lundbeck on Wednesday slightly lowered its 2021 sales outlook as strong growth for its leading products was not enough to offset greater-than-expected competition from generic drugs, sending its shares down more than 6%. Sales of Northera, used to treat disorders caused by an underlying neurological disease, are expected to drop by 75% this year down from a previous forecast for a 70% decline. "Northera did erode much more quickly in the early phases than we had anticipated," Chief Executive Deborah Dunsire told Reuters.